In this edition of the Explained series, find out what it means for the fight against COVID-19.
AstraZeneca-Oxford COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data from the Lancet showed on July 20. The AZD1222 vaccine did not prompt any serious side-effects and elicited anti-body and T-cell immune responses.
In this edition of the Explained series, find out what it means for the fight against COVID-19.First Published on Jul 21, 2020 08:54 pm
